Relay Therapeutics (RLAY) Other Non-Current Assets (2019 - 2026)

Relay Therapeutics (RLAY) has 8 years of Other Non-Current Assets data on file, last reported at $1.3 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 36.95% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 36.95% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 36.95% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $1.3 million, roughly flat from $1.3 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for RLAY reached as high as $2.7 million in Q2 2023 and fell as low as $1.3 million in Q4 2025.
• Historically, Other Non-Current Assets has averaged $2.4 million across 5 years, with a median of $2.6 million in 2022.
• Across the five-year window, Other Non-Current Assets jumped 193.62% in 2022 and tumbled 36.95% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $2.6 million in 2022, then advanced by 5.0% to $2.7 million in 2023, then retreated by 21.72% to $2.1 million in 2024, then tumbled by 36.95% to $1.3 million in 2025, then changed by 0.0% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $2.3 million in Q3 2025.